Toshisuke Morita

4.8k total citations · 1 hit paper
71 papers, 3.9k citations indexed

About

Toshisuke Morita is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Toshisuke Morita has authored 71 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Physiology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Toshisuke Morita's work include Heme Oxygenase-1 and Carbon Monoxide (16 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nitric Oxide and Endothelin Effects (6 papers). Toshisuke Morita is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (16 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nitric Oxide and Endothelin Effects (6 papers). Toshisuke Morita collaborates with scholars based in Japan, United States and South Korea. Toshisuke Morita's co-authors include Stella Kourembanas, Yuxiang Liu, Helen Christou, Shigehiro Katayama, Hideo Koike, Hiroki Kurihara, Junko Tatebe, S. Alex Mitsialis, Yoshio Yazaki and Gen Yoshino and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Toshisuke Morita

68 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxia Regulates Vascular Endothelial Growth Factor Gene Expression in Endothelial Cells

1995 822 citations Toshisuke Morita, Stella Kourembanas et al. profile →

Peers

Countries citing papers authored by Toshisuke Morita

Since Specialization

Citations

This map shows the geographic impact of Toshisuke Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshisuke Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshisuke Morita more than expected).

Fields of papers citing papers by Toshisuke Morita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshisuke Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshisuke Morita. The network helps show where Toshisuke Morita may publish in the future.

Co-authorship network of co-authors of Toshisuke Morita

This figure shows the co-authorship network connecting the top 25 collaborators of Toshisuke Morita. A scholar is included among the top collaborators of Toshisuke Morita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshisuke Morita. Toshisuke Morita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Usefulness of cerebrospinal fluid presepsin (soluble CD14 subtype) as a new marker in the diagnosis of neurosurgical postoperative meningitis 2024 ·Frontiers in Neurology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Toshisuke Morita, Nobuo Sugo	0
2	Urinary excretion of thyroid hormone in CKD patients: a proof-of-concept of nephrogenic hypothyroidism 2023 ·Renal Failure ·(unknown), Masaki Muramatsu, Akinobu Saito, (unknown), Toshisuke Morita, Yuko Hamasaki, Ken Sakai	5
3	Quantitative evaluation of insulin‐induced abdominal subcutaneous dystrophic tissue using shear wave elastography 2022 ·Journal of Diabetes Investigation ·(unknown), Hiroshi Uchino, Yosuke Shimizu, Junko Tatebe, Toshisuke Morita, Takahisa Hirose	2
4	Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis 2021 ·Journal of Infection and Chemotherapy ·Toshiaki Ishii, Masakazu Sasaki, (unknown), Daiki Kato, (unknown), Kotaro Aoki, Toshisuke Morita, Yoshikazu Ishii, Kazuhiro Tateda	21
5	Complete whole-genome sequence of the novel Pseudomonas species strain TUM18999, isolated from a patient with a burn wound in Japan 2021 ·Journal of Global Antimicrobial Resistance ·(unknown), Kotaro Aoki, Tatsuya Nagasawa, Masakazu Sasaki, Hinako Murakami, Toshiaki Ishii, (unknown), Toshisuke Morita, Yoshikazu Ishii, Kazuhiro Tateda	6
6	INDOXYL SULFATE IS A KEY PLAYER IN THE CARDIORENAL ANEMIA SYNDROME AND PREDICTS THE CLINICAL OUTCOME AFTER ACUTE DECOMPENSATED HEART FAILURE 2020 ·Journal of the American College of Cardiology ·Ippei Watanabe, Junko Tatebe, (unknown), Hideki Koike, Takanori Ikeda, Toshisuke Morita	0
7	Role of growth hormone signaling pathways in the development of atherosclerosis 2020 ·Growth Hormone & IGF Research ·Mayumi Ishikawa, (unknown), Takashi Yagi, Koji Kuboki, Toshisuke Morita, Hitoshi Sugihara, Takahisa Hirose, Shiro Minami, Gen Yoshino	2
8	Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis 2020 ·Respiratory Investigation ·Takuma Isshiki, (unknown), Tetsuo Yamaguchi, Toshisuke Morita, Junya Ono, Satoshi Nunomura, Kenji Izuhara, Susumu Sakamoto, Sakae Homma, Kazuma Kishi	8
9	The Difference in the Changes of Indoxyl Sulfate after Catheter Ablation among Atrial Fibrillation Patients with and without Kidney Dysfunction 2020 ·Scientific Reports ·Hideki Koike, Toshisuke Morita, Junko Tatebe, Ippei Watanabe, (unknown), Toshio Kinoshita, Hitomi Yuzawa, Takeya Suzuki, Tadashi Fujino, Takanori Ikeda	2
10	The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction 2018 ·Heart and Vessels ·Hideki Koike, Toshisuke Morita, Junko Tatebe, Ippei Watanabe, (unknown), (unknown), (unknown), Hitomi Yuzawa, Takeya Suzuki, Tadashi Fujino, Takanori Ikeda	11
11	Effect of rosuvastatin on concentrations of plasma lipids, urine and plasma oxidative stress markers, and plasma high-sensitivity C-reactive protein in hypercholesterolemic patients with and without type 2 diabetes mellitus: A 12-week, open-label, pilot study 2009 ·Current Therapeutic Research ·Gen Yoshino, Manabu Tanaka, (unknown), Tomoko Matsumoto, (unknown), Eiichi Murakami, Toshisuke Morita	7
12	Heme Oxygenase-1 in Vascular Smooth Muscle Cells Counteracts Cardiovascular Damage Induced by Angiotensin II 2005 ·Current Neurovascular Research ·Toshisuke Morita, T. Imai, Takao Sugiyama, Shigehiro Katayama, Gen Yoshino	18
13	Erectile Dysfunction in Hypertensive Rats Results from Impairment of the Relaxation Evoked by Neurogenic Carbon Monoxide and Nitric Oxide 2004 ·Hypertension Research ·(unknown), Toshisuke Morita, (unknown), Shinji Yagi, Shigehiro Katayama	70
14	Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats 2004 ·Biochemical and Biophysical Research Communications ·(unknown), Pawel M. Kaminski, Liming Yang, Toshisuke Morita, Muneo Inaba, Susumu Ikehara, Alvin I. Goodman, Michael S. Wolin, Nader G. Abraham	70
15	Combined Treatment with an AT1 Receptor Blocker and Angiotensin Converting Enzyme Inhibitor Has an Additive Effect on Inhibiting Neointima Formation via Improvement of Nitric Oxide Production and Suppression of Oxidative Stress 2004 ·Hypertension Research ·Shinji Yagi, Toshisuke Morita, Shigehiro Katayama	32
16	Carbon monoxide regulates blood pressure cooperatively with nitric oxide in hypertensive rats 2002 ·Heart and Vessels ·(unknown), Toshisuke Morita, Shigehiro Katayama	29
17	[Participation of interleukin-6 to skeletal muscle proteolysis: the effect of IL-6 administration on mRNA expression by the skeletal muscle cell proteolytic system]. 1998 ·PubMed ·Junya Fujita, Toshimasa Tsujinaka, (unknown), (unknown), Toshisuke Morita, Hiroya Taniguchi, Hitoshi Shiozaki, (unknown)	2
18	Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. 1995 ·Journal of Clinical Investigation ·Toshisuke Morita, Stella Kourembanas	299
19	Disruption of cytoskeletal structures mediates shear stress-induced endothelin-1 gene expression in cultured porcine aortic endothelial cells. 1993 ·Journal of Clinical Investigation ·Toshisuke Morita, Hiroki Kurihara, Koji Maemura, M Yoshizumi, Y Yazaki	105
20	Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells 1990 ·Biochemical and Biophysical Research Communications ·Masao Yoshizumi, Hiroki Kurihara, Toshisuke Morita, Takahiro Yamashita, Yoshio Oh-hashi, Takao Sugiyama, Fumimaro Takaku, Masashi Yanagisawa, Tomoh Masaki, Yoshio Yazaki	219

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact